Suppr超能文献

一名患有沃尔夫-赫希霍恩综合征女孩从出生到最终身高的生长轨迹和青春期节奏。

Growth trajectory and pubertal tempo from birth till final height in a girl with Wolf-Hirschhorn syndrome.

作者信息

Siew Jia Xuan, Yap Fabian

机构信息

Paediatric Medicine, KK Women's and Children's Hospital, Singapore, Singapore.

Paediatric Endocrinology, KK Women's and Children's Hospital, Singapore, Singapore.

出版信息

Endocrinol Diabetes Metab Case Rep. 2018 Apr 12;2018. doi: 10.1530/EDM-18-0001. eCollection 2018.

Abstract

UNLABELLED

Growth anomaly is a prominent feature in Wolf-Hirschhorn syndrome (WHS), a rare congenital disorder caused by variable deletion of chromosome 4p. While growth charts have been developed for WHS patients 0-4 years of age and growth data available for Japanese WHS patients 0-17 years, information on pubertal growth and final height among WHS children remain lacking. Growth hormone (GH) therapy has been reported in two GH-sufficient children with WHS, allowing for pre-puberty catch up growth; however, pubertal growth and final height information was also unavailable. We describe the complete growth journey of a GH-sufficient girl with WHS from birth until final height (FH), in relation to her mid parental height (MPH) and target range (TR). Her growth trajectory and pubertal changes during childhood, when she was treated with growth hormone (GH) from 3 years 8 months old till 6 months post-menarche at age 11 years was fully detailed.

LEARNING POINTS

Pubertal growth characteristics and FH information in WHS is lacking.While pre-pubertal growth may be improved by GH, GH therapy may not translate to improvement in FH in WHS patients.Longitudinal growth, puberty and FH data of more WHS patients may improve the understanding of growth in its various phases (infancy/childhood/puberty).

摘要

未标注

生长异常是Wolf-Hirschhorn综合征(WHS)的一个突出特征,WHS是一种由4号染色体短臂可变缺失引起的罕见先天性疾病。虽然已经为0至4岁的WHS患者制定了生长图表,并且有日本0至17岁WHS患者的生长数据,但WHS儿童青春期生长和最终身高的信息仍然缺乏。有报道称,两名生长激素(GH)充足的WHS儿童接受了GH治疗,实现了青春期前的追赶生长;然而,青春期生长和最终身高的信息也不可得。我们描述了一名生长激素充足的WHS女孩从出生到最终身高(FH)的完整生长历程,并将其与她的父母平均身高(MPH)和目标范围(TR)进行了比较。详细记录了她童年时期的生长轨迹和青春期变化,她在3岁8个月至11岁月经初潮后6个月期间接受了生长激素(GH)治疗。

学习要点

WHS患者缺乏青春期生长特征和最终身高信息。虽然青春期前的生长可能通过GH得到改善,但GH治疗可能无法使WHS患者最终身高得到改善。更多WHS患者的纵向生长、青春期和最终身高数据可能会增进对其不同阶段(婴儿期/儿童期/青春期)生长的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea7/5900798/ebecb280c81c/edmcr-2018-180001-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验